Welcomes MEPs' Rejection of Cadmium Quantum Dots

RNS Number : 8094N

Nanoco Group PLC

20 May 2015

 

For immediate release

20 May 2015

NANOCO GROUP PLC

("Nanoco" or the "Company") 

Welcomes MEPs' Rejection of Cadmium in Quantum Dots

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, confirms that Members of the European Parliament ("MEPs") have voted against a proposed extension of an exemption to the Restriction of Hazardous Substances Directive (RoHS) which would have allowed the use of cadmium-containing quantum dots in Europe.

Nanoco welcomes this decision by MEPs owing to the threat posed by cadmium to human health and to the environment.

Michael Edelman, Nanoco's Chief Executive Officer, said: "We are very pleased by this decision by the European Parliament and we would like to thank MEPs for the time they have taken to understand the detail and implications of the proposed exemption.

"Cadmium-free quantum dots are without question the preferred choice for human and environmental health. Such quantum dots have significant technological benefits and they are available today. We look forward to their increasingly widespread use throughout Europe, and worldwide, in multiple applications including enhanced LCD displays."

For further information, please contact:

Nanoco	Tel: [phone]
Michael Edelman, Chief Executive Officer
Mark Sullivan, Interim Chief Financial Officer
Canaccord Genuity - Joint Broker	Tel: [phone]
Simon Bridges
Cameron Duncan Mark Whitmore
Liberum - Joint Broker	Tel: [phone]
Simon Atkinson
Richard Bootle
Buchanan	Tel: [phone]
Mark Court / Sophie Cowles / Stephanie Watson

Notes for editors:

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

END

 

 

MSCLLFFVESIIFIE